DE69628762D1 - Vorrichtung zur verabreichung eines arzneistoffes - Google Patents

Vorrichtung zur verabreichung eines arzneistoffes

Info

Publication number
DE69628762D1
DE69628762D1 DE69628762T DE69628762T DE69628762D1 DE 69628762 D1 DE69628762 D1 DE 69628762D1 DE 69628762 T DE69628762 T DE 69628762T DE 69628762 T DE69628762 T DE 69628762T DE 69628762 D1 DE69628762 D1 DE 69628762D1
Authority
DE
Germany
Prior art keywords
administering
medicinal product
medicinal
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69628762T
Other languages
English (en)
Other versions
DE69628762T2 (de
Inventor
J Godbey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of DE69628762D1 publication Critical patent/DE69628762D1/de
Application granted granted Critical
Publication of DE69628762T2 publication Critical patent/DE69628762T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DE69628762T 1995-12-22 1996-12-19 Vorrichtung zur verabreichung eines arzneistoffes Expired - Fee Related DE69628762T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/577,482 US5702720A (en) 1995-12-22 1995-12-22 Transdermal device for the delivery of flurbiprofen
US577482 1995-12-22
PCT/US1996/020201 WO1997023206A1 (en) 1995-12-22 1996-12-19 Drug delivery device

Publications (2)

Publication Number Publication Date
DE69628762D1 true DE69628762D1 (de) 2003-07-24
DE69628762T2 DE69628762T2 (de) 2004-04-29

Family

ID=24308917

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69628448T Expired - Fee Related DE69628448T2 (de) 1995-12-22 1996-12-16 Transdermale verabreichungsform von flurbiprofen
DE69628762T Expired - Fee Related DE69628762T2 (de) 1995-12-22 1996-12-19 Vorrichtung zur verabreichung eines arzneistoffes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69628448T Expired - Fee Related DE69628448T2 (de) 1995-12-22 1996-12-16 Transdermale verabreichungsform von flurbiprofen

Country Status (22)

Country Link
US (2) US5702720A (de)
EP (2) EP0869781B1 (de)
JP (2) JP2000503638A (de)
KR (2) KR19990076588A (de)
CN (2) CN1098071C (de)
AR (1) AR005163A1 (de)
AT (2) ATE241350T1 (de)
AU (2) AU701782B2 (de)
CA (2) CA2238400A1 (de)
CO (1) CO4810224A1 (de)
CZ (2) CZ197298A3 (de)
DE (2) DE69628448T2 (de)
HR (1) HRP960608B1 (de)
HU (1) HUP9901991A3 (de)
IL (2) IL124629A (de)
MX (2) MX9804871A (de)
MY (1) MY113685A (de)
NO (2) NO982613L (de)
NZ (2) NZ325659A (de)
TW (1) TW436298B (de)
WO (2) WO1997023205A1 (de)
ZA (1) ZA9610729B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
DE19830649C2 (de) * 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
DE19834496B4 (de) 1998-07-31 2004-02-26 Beiersdorf Ag Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen
DE19840191A1 (de) * 1998-09-03 2000-03-09 Lohmann Therapie Syst Lts Arzneistoffhaltiges Pflaster mit drei funktionalen Schichten
US7052714B1 (en) * 1999-10-13 2006-05-30 Senju Pharmaceutical Co., Ltd Ophthalmic adhesive preparations for percutaneous adsorption
US20020110585A1 (en) 1999-11-30 2002-08-15 Godbey Kristin J. Patch therapeutic agent delivery device having texturized backing
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
WO2002102390A1 (en) * 2001-06-18 2002-12-27 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
US6805878B2 (en) * 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
US6951642B2 (en) 2001-09-28 2005-10-04 3M Innovative Properties Company Water-in-oil emulsions with anionic groups, compositions, and methods
US7030203B2 (en) 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
US20030152612A1 (en) * 2002-01-03 2003-08-14 Pugliese Peter T. Method and article to control cellulite
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US6838078B2 (en) 2002-01-16 2005-01-04 3M Innovative Properties Company Film-forming compositions and methods
DE10212864B4 (de) * 2002-03-22 2005-12-22 Beiersdorf Ag Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
KR100517101B1 (ko) * 2002-07-31 2005-09-27 한국과학기술연구원 이중 자극 응답성 하이드로젤 및 이의 제조 방법
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
US7479132B2 (en) 2003-03-10 2009-01-20 Tokuyama Corporation Patch material for ionic medicine administration
CA2529852A1 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating hiv
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
CA2556422A1 (en) * 2004-02-17 2005-08-01 Cook Biotech Incorporated Medical devices and methods for applying bolster material
US20060078604A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
US8551979B2 (en) * 2004-11-05 2013-10-08 Lead Chemical Co., Ltd. Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
KR100663163B1 (ko) 2005-10-24 2007-01-02 (주)아모레퍼시픽 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
EP2046307A2 (de) * 2006-06-14 2009-04-15 Arrow Coated Products Limited Vorrichtung zur verabreichung von wirkstoffen an menschen, tiere und pflanzen
KR20080006960A (ko) * 2006-07-14 2008-01-17 (주)아모레퍼시픽 소수성 비스테로이드성 소염진통제를 함유하는 경피 투여제제
US20080039415A1 (en) * 2006-08-11 2008-02-14 Gregory Robert Stewart Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
JP5214223B2 (ja) * 2007-11-15 2013-06-19 船井電機株式会社 プロジェクタ
US20090291140A1 (en) * 2008-05-21 2009-11-26 Andrew Korey Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs
WO2010077096A2 (ko) * 2008-12-31 2010-07-08 한올바이오파마주식회사 약물전달기구
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
US8906275B2 (en) 2012-05-29 2014-12-09 Nike, Inc. Textured elements incorporating non-woven textile materials and methods for manufacturing the textured elements
US9682512B2 (en) 2009-02-06 2017-06-20 Nike, Inc. Methods of joining textiles and other elements incorporating a thermoplastic polymer material
US8850719B2 (en) 2009-02-06 2014-10-07 Nike, Inc. Layered thermoplastic non-woven textile elements
US20100199520A1 (en) * 2009-02-06 2010-08-12 Nike, Inc. Textured Thermoplastic Non-Woven Elements
US20100199406A1 (en) 2009-02-06 2010-08-12 Nike, Inc. Thermoplastic Non-Woven Textile Elements
CN101502499B (zh) * 2009-03-13 2011-07-27 北京化工大学 一种布洛芬经皮释放贴剂及其制备方法
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
EP2504367A4 (de) 2009-11-23 2015-10-14 Isp Investments Inc Reaktive lösung aus polymerisierbaren polymeren mit polymerisierbaren reaktionsfunktionen sowie verfahren dafür und zusammensetzungen damit
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
US20130255103A1 (en) 2012-04-03 2013-10-03 Nike, Inc. Apparel And Other Products Incorporating A Thermoplastic Polymer Material
ITMI20121428A1 (it) * 2012-08-10 2014-02-11 Allergosystem S R L Dispositivo per applicazione topica di medicamenti o cosmetici
RU2016134903A (ru) * 2014-01-29 2018-03-01 Нитто Денко Корпорейшн Композиция для ускорения проникновения через кожу, препарат для трансдермального введения и препарат трансдермального пластыря
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
WO2018074261A1 (ja) * 2016-10-17 2018-04-26 第一三共株式会社 封入容器の製造方法及び製造装置
WO2018124089A1 (ja) 2016-12-28 2018-07-05 久光製薬株式会社 貼付剤
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US24906A (en) * 1859-07-26 Simeon goodfellow
USRE24906E (en) * 1955-11-18 1960-12-13 Pressure-sensitive adhesive sheet material
US3949128A (en) * 1972-08-22 1976-04-06 Kimberly-Clark Corporation Product and process for producing a stretchable nonwoven material from a spot bonded continuous filament web
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
JPS55139313A (en) * 1979-04-16 1980-10-31 Ota Seiyaku Kk Gel cream composition comprising higher fatty acid ethanol amide, and drug containing it
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US5445604A (en) * 1980-05-22 1995-08-29 Smith & Nephew Associated Companies, Ltd. Wound dressing with conformable elastomeric wound contact layer
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4477468A (en) * 1982-12-06 1984-10-16 The Upjohn Company Treatment of type II herpes virus with flurbiprofen
US4701470A (en) * 1982-12-06 1987-10-20 The Upjohn Company Treatment of Type II Herpes virus with ibuprofen
US4473584A (en) * 1982-12-06 1984-09-25 The Upjohn Company Treatment of Type I Herpes virus with flurbiprofen
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
CH662944A5 (it) * 1984-10-18 1987-11-13 Pier Luigi Prof Dr Luisi Procedimento per la preparazione di biocompatibili di micelle inverse di biocompatibili e loro utilizzazione.
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
US5230701A (en) * 1988-05-13 1993-07-27 Minnesota Mining And Manufacturing Company Elastomeric adhesive and cohesive materials
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
WO1991006295A1 (en) * 1989-11-06 1991-05-16 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
AU7850491A (en) * 1990-05-18 1991-12-10 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
TW218849B (de) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5478567A (en) * 1991-08-30 1995-12-26 Hisamitsu Pharmaceutical Co., Inc. Antiphlogistic analgesic plaster
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
JPH08509222A (ja) * 1993-04-22 1996-10-01 ミネソタ マイニング アンド マニュファクチャリング カンパニー 経皮抗炎症性組成物

Also Published As

Publication number Publication date
CO4810224A1 (es) 1999-06-30
NO982764D0 (no) 1998-06-15
US6086911A (en) 2000-07-11
ATE241350T1 (de) 2003-06-15
WO1997023206A1 (en) 1997-07-03
NO982764L (no) 1998-06-15
TW436298B (en) 2001-05-28
DE69628448D1 (de) 2003-07-03
IL124804A0 (en) 1999-01-26
CZ197198A3 (cs) 1998-11-11
IL124804A (en) 2001-12-23
MY113685A (en) 2002-04-30
CN1205631A (zh) 1999-01-20
EP0869781A1 (de) 1998-10-14
US5702720A (en) 1997-12-30
MX9804871A (es) 1998-10-31
KR19990076588A (ko) 1999-10-15
HUP9901991A3 (en) 2001-04-28
AU1422097A (en) 1997-07-17
HRP960608B1 (en) 2001-12-31
CN1098069C (zh) 2003-01-08
CA2240349A1 (en) 1997-07-03
NO982613L (no) 1998-08-21
IL124629A0 (en) 1998-12-06
CN1098071C (zh) 2003-01-08
AU701782B2 (en) 1999-02-04
CZ197298A3 (cs) 1999-01-13
KR19990076589A (ko) 1999-10-15
EP0868177B1 (de) 2003-06-18
NZ325125A (en) 2000-05-26
KR100452001B1 (ko) 2004-12-30
JP2000502349A (ja) 2000-02-29
WO1997023205A1 (en) 1997-07-03
AU714798B2 (en) 2000-01-13
DE69628448T2 (de) 2004-04-08
MX9804969A (es) 1998-09-30
JP2000503638A (ja) 2000-03-28
EP0868177A1 (de) 1998-10-07
ATE243031T1 (de) 2003-07-15
HRP960608A2 (en) 1997-10-31
AR005163A1 (es) 1999-04-14
ZA9610729B (en) 1998-06-19
NO982613D0 (no) 1998-06-05
EP0869781B1 (de) 2003-05-28
CN1205630A (zh) 1999-01-20
IL124629A (en) 2001-10-31
DE69628762T2 (de) 2004-04-29
HUP9901991A2 (hu) 1999-10-28
NZ325659A (en) 2000-02-28
CA2238400A1 (en) 1997-07-03
AU1295097A (en) 1997-07-17

Similar Documents

Publication Publication Date Title
DE69628762D1 (de) Vorrichtung zur verabreichung eines arzneistoffes
DE59307970D1 (de) Einrichtung zur abgabe eines arzneimittels
DE69623709D1 (de) Vorrichtung zum Verabreichen von Medikamenten
DE69628344D1 (de) Vorrichtung zur Verabreichung einer Substanz
DE69619968D1 (de) Vorrichtung zur Abgabe eines flüchtigen Wirkstoffs
DE69422907D1 (de) Vorrichtung zum in-line verabreichen einer arznei
DE69637358D1 (de) Gerät zur Kontrolle eines physiologischen Zustands
DE59600843D1 (de) Vorrichtung zur Herstelllung eines Einkristalls
DE69517169T2 (de) Vorrichtung zur abgabe von medikamenten
DE69621345D1 (de) Vorrichtung zur austragung eines biologischen wirkstoffes
DE69631531D1 (de) Katheter zur verabreidung von arzneien
DE69931354D1 (de) Vorrichtung zum verabreichen eines medikamentes
DE69306292T2 (de) Vorrichtung zur Einspritzung eines Medikaments
DE69614044T2 (de) Vorrichtung zur Halterung eines Rollstuhls
DE69507927T2 (de) Vorrichtung zur Verschieben eines Produktes
DE69500328T2 (de) Vorrichtung zur Abgabe eines flüssigen oder festen Produktes
DE69625637D1 (de) Vorrichtung zur Durchführung eines Fellenverschönerungsverfahrens
DE69304557D1 (de) Vorrichtung zur Herstellung eines Nahrungsmittelprodukts
DE9409136U1 (de) Vorrichtung zur Größenänderung eines Behältnisses
DE29512146U1 (de) Vorrichtung zur Colon-Hydro-Therapie eines Patienten
DE29513048U1 (de) Vorrichtung zur Verpackung eines Bauteils
DE9311676U1 (de) Vorrichtung zur Produktpräsentation
DE9318939U1 (de) Vorrichtung zum Erzeugen eines Aufgusses medizinischer Kräuter
DE69516690T2 (de) Vorrichtung zur Reduzierung von Nahrungsmitteleinnahme eines Patienten
DE69633466D1 (de) Eine Vorrichtung zum Verabreichen von oralen Wirkstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee